Scarica l'app Stockscreener
222.04
0.37%
0.82
Dopo l'orario di chiusura:
222.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RMD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Resmed Inc Borsa (RMD) Ultime notizie
Global Respiratory Care Devices Market to Grow at a Substantial Growth Rate of ~8% by 2034 | DelveInsight - GlobeNewswire Inc.
OVERSEA CHINESE BANKING Corp Ltd Sells 7,795 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch
Mirae Asset Global Investments Co. Ltd. Boosts Position in ResMed Inc. $RMD - MarketBeat
ResMed Inc stock (US75102W1036): Is its sleep apnea dominance strong enough for long-term investor g - AD HOC NEWS
ResMed Inc. stock (US7611521078): Is its sleep apnea dominance strong enough for long-term investor - AD HOC NEWS
ResMed Inc. (RMD) stock price, news, quote and history - Yahoo Finance Singapore
Why ResMed (RMD) is Poised to Beat Earnings Estimates Again - Yahoo Finance
ResMed Inc. stock (US7611521078): Is the U.S. sleep apnea market strong enough to unlock new upside? - AD HOC NEWS
ResMed Inc. (RMD) Investor Outlook: Unveiling a 28% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
JPMorgan Issues Overweight Rating for ResMed Amid Sleep Apnea Shift - HarianBasis.co
JPMorgan Initiates ResMed (RMD) With “Overweight” Rating and A$37.6 PT - Insider Monkey
Mizuho Maintains ResMed Inc.Depositary Receipt (RSMDF) Outperform Recommendation - MSN
Lbp Am Sa Buys 18,142 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc. stock rises Friday, outperforms market - MarketWatch
Should you continue to hold Resmed stock in your portfolio? - MSN
Should You Continue to Hold Resmed Stock in Your Portfolio? - TradingView
KBC Group NV Has $57.23 Million Position in ResMed Inc. $RMD - MarketBeat
Hendershot Investments Inc. Increases Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc. stock falls Thursday, underperforms market - MarketWatch
INVESCO V.I. Health Care Fund's ResMed Inc(RMD) Holding History - GuruFocus
ResMed, Inc. Experiences Valuation Adjustment Amid Competitive Market Landscape - Markets Mojo
Down 38% this year, is it finally time to buy low on CSL, ResMed and Pro Medicus shares? - The Motley Fool Australia
ResMed Inc. stock (US7611521078): Why does its sleep apnea dominance matter more now? - AD HOC NEWS
ResMed (NYSE:RMD) Now Covered by JPMorgan Chase & Co. - MarketBeat
Baird Adjusts Price Target on ResMed to $254 From $272, Maintains Neutral Rating - marketscreener.com
ResMed Inc. $RMD Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
ResMed Inc. stock (US7611521078): Is sleep apnea market growth strong enough to unlock new upside? - AD HOC NEWS
ResMed Inc. $RMD Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
RMD Analyst Rating Maintained at Outperform by Evercore ISI - Meyka
ResMed Inc (NYSE:RMD): A Durable Dividend Growth Stock for Passive Income - ChartMill
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Receives a Buy from Ord Minnett - The Globe and Mail
Wells Fargo Analyst Raises ResMed (RMD) Price Target to $270 | R - GuruFocus
ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh Trade Ideas — LSX:935168 - TradingView
ResMed Faces Shifting Market Signals in Healthcare Space - Kalkine Media
ResMed (NYSE:RMD) CEO Michael Farrell Sells 4,991 Shares - MarketBeat
Citigroup Issues Pessimistic Forecast for ResMed (NYSE:RMD) Stock Price - MarketBeat
Resmed CEO Farrell sells $1.12 million in stock - Investing.com
Resmed CEO Farrell sells $1.12 million in stock By Investing.com - Investing.com Australia
ResMed (RMD) CEO Farrell sells 4,991 shares after option exercise - Stock Titan
ResMed Insider Selling Raises Questions On Management Conviction And Valuation - Sahm
ResMed Inc. stock rises Wednesday, still underperforms market - MarketWatch
Citigroup Adjusts Price Target on ResMed to $340 From $345, Maintains Buy Rating - marketscreener.com
ResMed Inc. $RMD Shares Sold by Pacific Point Advisors LLC - MarketBeat
ResMed CEO Michael Farrell Plans Additional Insider Sale Under Rule 144 - TipRanks
Affiliate plans sale of 4,991 RMD shares via Fidelity (NYSE: RMD) - Stock Titan
Is Now The Time To Put ResMed (NYSE:RMD) On Your Watchlist? - Moomoo
Robinhood Asset Management Boosts ResMed Stake - National Today
Sleep Apnea Devices Market to Reach Strong Growth Through 2033 - openPR.com
ResMed Adjusts CDI and Share Balances Amid Transfers, Equity Issuance and Buybacks - TipRanks
ResMed Officer Sandercock Discloses Ongoing Insider Share Sales Under Rule 144 - TipRanks
4,837 Shares in ResMed Inc. $RMD Acquired by Runnymede Capital Advisors Inc. - MarketBeat
Wealth Enhancement Advisory Services LLC Has $1.66 Million Stock Holdings in ResMed Inc. $RMD - MarketBeat
Element Squared LLC Buys Shares of 6,067 ResMed Inc. $RMD - marketbeat.com
Aberdeen Group Reduces Stake in ResMed Inc. - National Today
Aberdeen Group plc Sells 37,737 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc. (NYSE:RMD) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
1.79%
0.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):